InvestSMART

Echo IQ Limited (ASX:EIQ)

ALERT: Price-sensitive ASX Announcement for EIQ
Current share price for EIQ : $0.440 -0.875 (-66.54%)+
Announcement
Release
27 Jul 2026 9:44AM
Price at Release
$1.315
Full Release
download
Summary
Echo IQ Limited reported significant achievements in its quarterly activities, including strategic partnerships, financial strengthening, and progress in U.S. commercial expansion. The company executed a Heads of Agreement with Pro Medicus Limited for a strategic investment and partnership, aiming to leverage Pro Medicus' extensive U.S. network. A $110 million institutional placement was completed to support this expansion. Echo IQ's U.S. commercial pipeline now includes over 70 hospitals, and the company has processed over 10,200 echocardiograms, showing significant growth. An exclusive data licensing agreement with Advara HeartCare was secured to enhance AI product development. The company continues to focus on FDA clearance for its EchoSolv HF product and is preparing for a commercial launch. Financially, Echo IQ reported cash equivalents of $8.7 million at the quarter's end.
Key Points
  • Echo IQ executed a strategic partnership with Pro Medicus Limited.
  • Completed a $110 million institutional placement.
  • U.S. commercial pipeline expanded to over 70 hospitals.
  • Processed over 10,200 echocardiograms, increasing commercial adoption.
  • Secured a data licensing agreement with Advara HeartCare.
  • Focus on FDA clearance and potential U.S. commercial launch of EchoSolv HF.
  • Reported cash equivalents of $8.7 million at the end of the quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.